Teva gets approval to buy Bentley

Teva Pharmaceutical Industries received nearly a 69 percent shareholder approval to complete its $360 million dollar purchase of Bentley Pharmaceuticals, a move the company hopes will help it to expand sales in Spain with over 170 products. Report.

Suggested Articles

xarelto
Pharma

AHA: J&J, Bayer still seeking answers in aborted Xarelto study

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

by Kyle Blankenship
Pharma

Novartis wins speedy FDA nod for sickle cell drug Adakveo

Novartis hopes to leverage its existing presence in the hematology community to achieve a successful launch of Adakveo.

by Angus Liu
Farxiga
Pharma

AHA: AZ's Farxiga data shows big benefit in non-diabetics

AstraZeneca's Farxiga is touting its heart failure data in patients with or without diabetes, but results in non-diabetics looks particularly strong.

by Kyle Blankenship